On Sept. 17, a key advisory panel to the U.S. Food and Drug Administration (FDA) issued a limited endorsement of Pfizer vaccine boosters. The FDA’s Vaccines and Related Biological Products Advisory Committee voted unanimously to endorse a booster shot of the Pfizer-BioNTech COVID-19 vaccination for two categories of people: those 65 and older, and those...
This content is restricted to members.
